Commission Decision of 26 November 2009 approving annual and multi-annual programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2010 and following years (notified under document C(2009) 9131) (2009/883/EC)

Article 4 U.K. Bluetongue in endemic or high risk areas

1. The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland and Sweden are hereby approved for the period from 1 January to 31 December 2010.

2. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out the vaccination, the laboratory tests for virological, serological and entomological surveillance and the purchase of traps and vaccines and shall not exceed:

(a) EUR 4 500 000 for Belgium;

(b) EUR 6 000 for Bulgaria;

(c) [F1 EUR 1 650 000] for the Czech Republic;

(d) EUR 50 000 for Denmark;

(e) [F1 EUR 1 700 000] for Germany;

(f) EUR 130 000 for Estonia;

(g) EUR 80 000 for Ireland;

(h) EUR 70 000 for Greece;

[F1 (i) EUR 19 000 000 for Spain;

(j) EUR 33 500 000 for France;]

(k) EUR 2 700 000 for Italy;

[F1 (l) EUR 20 000 for Latvia;

(m) EUR 10 000 for Lithuania;]

(n) EUR 300 000 for Luxembourg;

(o) [F1 EUR 70 000] for Hungary;

(p) EUR 4 000 for Malta;

(q) [F1 EUR 130 000] for the Netherlands;

(r) EUR 1 000 000 for Austria;

(s) EUR 70 000 for Poland;

(t) [F1 EUR 2 100 000] for Portugal;

(u) EUR 110 000 for Romania;

(v) [F1 EUR 40 000] for Slovenia;

(w) EUR 50 000 for Slovakia;

[F1 (x) EUR 20 000 for Finland;

(y) EUR 850 000 for Sweden.]

3. The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

for an ELISA test

EUR 2,5 per test;

for a PCR test

EUR 10 per test;

for the purchase of monovalent vaccines

EUR 0,3 per dose;

for the purchase of bivalent vaccines

EUR 0,45 per dose;

(e) for the administration of vaccines to bovine animals EUR 1,50 per bovine animal vaccinated, regardless of the number and types of doses used;

(f) for the administration of vaccines to ovine or caprine animals EUR 0,75 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.

Textual Amendments

F1 Substituted by Commission Decision of 30 November 2010 approving certain amended programmes for the eradication and monitoring of animal diseases and zoonoses for the year 2010 and amending Decision 2009/883/EC as regards the financial contribution by the Union for programmes approved by that Decision (notified under document C(2010) 8290) (2010/732/EU).